For in-vitro research use only. Not for human consumption.
Tirzepatide
Tirzepatide is a first-in-class dual incretin receptor agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. This dual mechanism of action allows researchers to study the synergistic effects of two key metabolic hormone pathways.
Tirzepatide definition
Tirzepatide is a first-in-class dual incretin receptor agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. This dual mechanism of action allows researchers to study the synergistic effects of two key metabolic hormone pathways.
No sequence is listed in the current catalog record for this product.
- CAS
- 2023788-19-2
- MW
- 4813.45 g/mol
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- C225H348N48O68
- Purity
- 99.55%
- Form
- Lyophilized powder
- Class
- Dual GIP/GLP-1 Receptor Agonist
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- CAS Number
- 2023788-19-2
- Molecular Weight
- 4813.45 g/mol
- Molecular Formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Class
- Dual GIP/GLP-1 Receptor Agonist
- Purity
- ≥99% purity
- Physical Form
- Lyophilized powder
- Storage
- Store at -20°C (long term). Refrigerate after reconstitution.
Research context.
Published data from the SURPASS and SURMOUNT clinical trial programs has generated significant interest in dual incretin signaling. Tirzepatide research has expanded understanding of how combined GIP and GLP-1 receptor activation may differ from GLP-1-only approaches in metabolic studies.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
Tirzepatide is part of the Nexus GLP-1 & Metabolic catalog. GLP-1, amylin, and multi-agonist metabolic research peptides. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
39-amino acid dual GIP/GLP-1 receptor agonist
Storage: Store at -20°C (long term). Refrigerate after reconstitution.
Technical specifications.
- Product Name: Tirzepatide
- Classification: Dual GIP/GLP-1 Receptor Agonist
- Structural Description: 39-amino acid dual GIP/GLP-1 receptor agonist
- CAS Number: 2023788-19-2
- Molecular Weight: 4813.45 g/mol
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
Tirzepatide research FAQ.
What is Tirzepatide used for in research?
Tirzepatide is supplied for controlled in-vitro research workflows in the GLP-1 & Metabolic category. It is not labeled for human or veterinary use.
Is Tirzepatide HPLC verified?
Tirzepatide is listed with Nexus lab verification. Current catalog records show 99.55% purity context where batch COA data is available.
Which Tirzepatide sizes are available?
Current Nexus variants include 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg, 120mg.
Does Tirzepatide include a COA?
Yes. The current Nexus record links Tirzepatide to batch NEX-TIRZEPATIDE-2026-0092.